Closer look at four of our recommendations

Here’s a look at some of the factors that make the three ETFs we see as buys on pages 3 and 4 attractive—and why we don’t like the fourth.
Healthy profits in healthcare equipment
With the onset of the COVID-19 pandemic, healthcare equipment providers were hurt as… Read More

Use these to boost your biotech exposure

Biotechnology companies have been at the forefront of some of the most exciting developments in healthcare over the past two decades—and there are more developments in the pipeline. However, the high cost of product development, long lead times for product testing and regulatory approvals, and… Read More